Platelet Rich Plasma Following Hysteroscopic Adhesolysis

N/ACompletedNCT03881215

Ain Shams University160 enrolled

Overview

Platelet Rich Plasma Following Hysteroscopic Adhesolysis: A Randomized Clinical Trial

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

160

Conditions

Intra-uterine Adhesions

Interventions

Platelet Rich PlasmaPROCEDURE

Platelet Rich Plasma

intra-uterine balloonPROCEDURE

intra-uterine balloon

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 40 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age: 18-40 years * Grade III intra-uterine adhesions Exclusion Criteria: * Age \< 18 or \> 40 years. * Hb \< 11 g/dL, platelets \< 150.000/mm3. * Patient taking anticoagulant. * Patient taking NSAID in the 10 days before procedure. * Any significant comorbidity or psychiatric disorder that would compromise patient's consent. * Active cervical or uterine infection. * Undiagnosed genital bleeding. * pregnancy.

Locations (1)

Ain Shams University Maternity Hospital

Cairo, Egypt

Outcomes

Primary Outcomes

Incidence of adhesion recurrence

recurrence of severe intra-uterine adhesions

Time frame: 3 months

Secondary Outcomes

Days of menses

Number of days of menstrual cycle following operation

Time frame: 3 months

Amount of menses

Number of sanitary pads changed during each menstrual cycle

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.